| Patricia Ann Rapan, LVN | |
|
760 West Mountainview St, Altadena, CA 91001 | |
| (626) 798-6793 | |
| (626) 797-9035 |
| Full Name | Patricia Ann Rapan |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 760 West Mountainview St, Altadena, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093833063 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | 136760 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Ann Rapan, LVN 13655 Leach St, Sylmar, CA 91342 Ph: (818) 898-2369 | Patricia Ann Rapan, LVN 760 West Mountainview St, Altadena, CA 91001 Ph: (626) 798-6793 |
News Archive
The Endocrine Society expressed continued concerns today that the European Union's (EU's) criteria for regulating endocrine-disrupting chemicals (EDCs) in pesticides and biocides do not go far enough to protect public health.
Research carried out by scientists at the University of Southampton has shown that simple tests in GP surgeries could potentially double the diagnosis rate of liver disease where patients are not displaying any symptoms.
A multi-institution project involving ten universities and led by the University of Granada (UGR) has designed a resource manual to measure the physical fitness of pre-school children and the prevalence of obesity—which affects up to 35% of children in this age range—in a bid to correct risk factors.
Mutations in a gene called XRCC2 cause increased breast cancer risk, according to a study published today in the American Journal of Human Genetics. The study looked at families that have a history of the disease but do not have mutations in the currently known breast cancer susceptibility genes.
MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that the first patient has been dosed in a Phase Ib clinical study of its investigational mitochondrial inhibitor drug candidate ME-344 in combination with Hycamtin (topotecan) in patients with solid tumors, including small cell lung and ovarian cancers.
› Verified 1 days ago
Mr. Victor Lorin Fuery Iii, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2807 Saint James Pl, Altadena, CA 91001 Phone: 323-443-3279 Fax: 323-443-3267 | |
Ms. Jill Cathleen Charney, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2933 El Nido Dr, Altadena, CA 91001 Phone: 626-395-7100 Fax: 626-798-2863 | |
Rebekah Kelly, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 760 Mountain View St, Altadena, CA 91001 Phone: 626-798-6793 | |
Mrs. Patricia Guizar, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 760 Mountain View St, Altadena, CA 91001 Phone: 626-798-6793 Fax: 626-797-9035 | |
Angie Sae Kung, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 760 W Mountain View St, Altadena, CA 91001 Phone: 626-798-6793 | |
Mr. Oscar Morales Aguirre, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2145 North Marengo Ave, Altadena, CA 91001 Phone: 626-376-3454 |